Clinical studies have demonstrated that the IL-23 in the synovium and serum of RA patients is abnormally elevated, and it can serve as a biomarker for RA diagnosis (Lapkina et al., 2025). This evidence concerns the gene IL37 and rheumatoid arthritis.